Sinopharm Tech Holdings Limited (8156.HK) HKSE

0.22

+0(+0.00%)

Updated at October 13 11:56AM

Currency In HKD

Valuation

Market Cap85.99M
Enterprise Value125.77M
P/E Ratio-7.68
PEG Ratio-0.08
Price/Sales Ratio1.66
Price/Book Ratio-3.76
Enterprise/Revenue2.13
Enterprise/EBITDA15.95

Fiscal Year

Fiscal YearJune 30, 2025
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.22
Operating Margin-0.19

Management Effectiveness

Return On Assets-0.35
Return On Equity0.27

Income Statement

Revenue61.25M
Revenue/Share0.13
Gross Profit13.52M
EBITDA6.11M
Net Income-867,000
Diluted EPS-0

Balance Sheet

Total Cash6.95M
Total Cash/Share0.01
Total Debt46.73M
Total Debt/Equity-1.27
Current Ratio0.72
Book Value Per Share-0.06

Price History

52-Week Change123.47
52-Week High0.44
52-Week Low0.09
Moving Average 50 Days0.28
Moving Average 200 Days0.18

Statistics

Average Volume154,078
Shares Outstanding633.69M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:25
Last Split DateSeptember 12, 2023